Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04675476 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Dec 31, 2025 → Dec 31, 2026
See other at-risk trials from Georgetown University

Record History

  1. Primary completion pushed from Dec 31, 2025 to Dec 31, 2026 Enrollment closed, study ongoing · Completion pushed from Feb 28, 2026 to Feb 28, 2027 · Interventions: Provider Prompt & Patient Outreach and Education (Behavioral) to Provider Prompt & Patient Outreach and Education (Behavioral) · 3 more Show 6 more changesShow less
    • Enrollment closed, study ongoing
    • Completion pushed from Feb 28, 2026 to Feb 28, 2027
    • Interventions: Provider Prompt & Patient Outreach and Education (Behavioral) to Provider Prompt & Patient Outreach and Education (Behavioral)
    • Eligibility criteria expanded, about 8 words
    • Site details revised
    • Publications: details revised at 2 of 2 entries
  2. Start date changed from estimate of Feb 19, 2024 to Mar 11, 2024v7
  3. Trial status: Active, Not Recruiting to Recruiting Start date: Jan 2, 2024 to Feb 19, 2024 · Primary completion date: Nov 30, 2025 to Dec 31, 2025 · Site details revisedv6 Show 3 more changesShow less
    • Start date: Jan 2, 2024 to Feb 19, 2024
    • Primary completion date: Nov 30, 2025 to Dec 31, 2025
    • Site details revised
  4. Trial status: Not Yet Recruiting to Active, Not Recruiting Study description expanded, about 80 wordsv5 Show 1 more changeShow less
    • Study description expanded, about 80 words

    See this version in full on ClinicalTrials.gov ↗

  5. Start date: Nov 1, 2023 to Jan 2, 2024v4
Show 2 earlier versionsHide 2 earlier versions
  1. Start date: Dec 1, 2022 to Nov 1, 2023 Primary completion date: Aug 31, 2025 to Nov 30, 2025 · Completion date: Nov 30, 2025 to Feb 28, 2026 · Eligibility criteria revisedv3 Show 3 more changesShow less
    • Primary completion date: Aug 31, 2025 to Nov 30, 2025
    • Completion date: Nov 30, 2025 to Feb 28, 2026
    • Eligibility criteria revised

    See this version in full on ClinicalTrials.gov ↗

  2. Study sites: 0 to 1v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To test the impact of a multilevel intervention on primary (provider-patient communication, intentions, and knowledge) and secondary (screening referrals and completion) outcomes.
Trial Details
NCT Number NCT04675476
Lead Sponsor Georgetown University
Conditions Lung Cancer
Enrollment 368 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov